期刊文献+

消化系统疾病药物治疗进展与评价——消化系统合理用药专家圆桌会议纪要 被引量:6

下载PDF
导出
摘要 泪竹青箬,近端午,促膝端坐一聚。试高低引经蹈矩,评点药石回瞬。基于本刊的一贯宗旨,7月9日由编辑部筹办在京召开"消化系统合理用药专家圆桌会议"。出席会议的专家有林三仁、周丽雅、韩英、于中麟、孙忠实、刘新光、杨昭徐、傅贤波、李世荣、张小晋、史丽敏、段京莉、蓝宇、李静、郝建宇等。会议由我国著名消化内科专家林三仁主任主持,5位医药学教授相继就肠易激综合征、5-羟色胺与其拮抗剂、反流性食管炎的治疗原则及再思考、幽门螺杆菌耐药与根除对策、胆石症的药物治疗进行主题发言,玉石激浪,仁智互碰,各抒己见,现将精华整理成篇,以励同仁。
作者 段宁 林三仁
出处 《中国医院用药评价与分析》 2008年第8期561-564,共4页 Evaluation and Analysis of Drug-use in Hospitals of China
  • 相关文献

参考文献8

  • 1Ashburn TT,Gupta MS. The IBS market[J]. Nat Rev Drug Discov, 2006,5 (2) : 99.
  • 2Egan B J, Katicic M, O' Connor H J, et al. Treatment of Helicobacter pylori[ J ]. Helicobacte, 2007,12 ( Suppl 1 ) : 31.
  • 3胡伏莲.重视幽门螺杆菌耐药菌株的研究[J].胃肠病学,2006,11(7):385-387. 被引量:30
  • 4Malfertheiner P, Megraud F, O' Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht Ⅲ Consensus Report [ J ]. Gut, 2007,56 (6) : 772.
  • 5Chey WD, Wong BC. Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection[J]. Am J Gastroenterol,2007,102(8) :1 808.
  • 6Gisbert JP, Gisbert JL, Marcos S, et al. Empirical rescue therapy after Helicobacter pylori treatment failure: a 10- year singlecentre study of 500 patients [ J ] . Aliment Pharmacol Ther ,2008,27 (4) :346.
  • 7Gisbert JP, Bermejo F, Castro - Fernandez M, et al. Second - line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients[J]. Am J Gastroenterol, 2008,103 ( 1 ) : 71.
  • 8赵大国,孙玉平,潘建军.10日序贯疗法根除幽门螺杆菌的疗效观察[J].中国医师进修杂志(内科版),2006,29(10):24-25. 被引量:27

二级参考文献22

  • 1刘晓峰,胡家露.幽门螺杆菌感染致病的宿主因素[J].国外医学(消化系疾病分册),2004,24(5):284-287. 被引量:23
  • 2成虹,胡伏莲.北京地区幽门螺杆菌耐药情况及其变化趋势[J].中华医学杂志,2005,85(39):2754-2757. 被引量:176
  • 3Megraud F.H.pylori antibiotic resistance:prevalence,importance,and advances in testing.Gut,2004,53:1374~1384.
  • 4Chinese H.pylori Study Group.Development in research on resistance of H.pylori to antibiotics.The 5th KoreaJapan-China Joint Conference on H.pylori Abstracts2006.ps20.23.
  • 5郑小丽,王蔚虹,胡伏莲.幽门螺杆菌耐药的分子机制.见:胡伏莲,周殿元主编.幽门螺杆菌感染的基础与临床.修订版.北京:中国科学技术出版社,2002.372~377.
  • 6van Zanten S J,Kolesnikow T,Leung V,O'Rourke JL,Lee A.Gastric transitional zones,areas where Helicobacter treatment fails:results of a treatment trial using the Sydney strain mouse model.Antimicrob Agents Chemother,2003,47:2249~2255.
  • 7Meyer JM,Silliman NP,Wang W,Siepman NY,Sugg JE,Morris D,Zhang J,Bhattacharyya H,King EC,Hopkins RJ.Risk factors for Helicobacter pylori resistance in the United States:the surveillance of H.pylori antimicrobial resistance partnership (SHARP) study,1993-1999.Ann Intern Med,2002,136:13~24.
  • 8Dore MP,Osato MS,Kwon DH,Graham DY,el-Zaatari FA.Demonstration of unexpected antibiotic resistance of genotypically identical Helicobacter pylori isolates.Clin Infect Dis,1998,27:84~89.
  • 9Broutet N,Tchamgoue S,Pereira E,Lamouliatte H,Salamon R,Megraud F.Risk factors for failure of Helicobacter pylori therapy -results of an individual data analysis of 2751 patients.Aliment Pharmacol Ther,2003,17:99~109.
  • 10Minami M,Ando T,Hashikawa SN,Torii K,Hasegawa T,Israel DA,Ina K,Kusugami K,Goto H,Ohta M.Effect of glycine on Helicobacter pylori in vitro.Antimicrob Agents Chemother,2004,48:3782~3788.

共引文献55

同被引文献56

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部